Benefits
Peak power output improvement in single dose
A published double-blind crossover RCT in 50 physically active men and women confirmed Zynamite® PX (140 mg + quercetin, single dose) improved peak power output by 2.8–3.8% during repeated Wingate sprint tests vs. placebo. This acute single-dose effect is unusual for polyphenol ingredients and reflects mangiferin's rapid oxygen utilization enhancement mechanism.
Basketball and team sport performance
An independent clinical study in national-level Greek basketball players confirmed Zynamite® PX significantly improved sprint speed, agility, and reduced perceived exertion during a basketball simulation test vs. placebo. This sport-specific evidence in elite athletes provides unusually strong ecological validity for real-world performance claims.
Exercise-induced muscle damage recovery
A recovery study (57 subjects, 10 km run + 100 drop jumps) confirmed Zynamite® PX (taken 1 hour pre-exercise and every 8 hours for 24 hours) significantly accelerated recovery from exercise-induced muscle damage vs. placebo — reducing CK elevation, muscle soreness, and functional impairment. This recovery application positions Zynamite® PX for post-workout and intra-workout formulas.
Oxygen utilization and exercise efficiency
The core mechanism (mangiferin's oxygen utilization enhancement) improves the efficiency of aerobic energy production — meaning athletes produce more ATP per unit oxygen consumed during exercise. This metabolic efficiency advantage contributes to both the acute power output benefits and the endurance/recovery benefits observed across 10+ clinical studies.
Mechanism of action
Mangiferin mitochondrial oxygen extraction and vascular NO enhancement
Mangiferin from Zynamite® enhances mitochondrial oxygen extraction efficiency by modulating complex I and II of the electron transport chain — improving ATP generation per O2 consumed. Quercetin enhances mangiferin bioavailability through P-glycoprotein inhibition and provides complementary eNOS/NO-mediated vasodilation improving oxygen and nutrient delivery to exercising muscle. The combined mitochondrial efficiency (mangiferin) + vascular delivery (quercetin-NO) mechanism explains the consistent performance improvements across power, sprint, endurance, and recovery endpoints.
Clinical trials
Randomized, double-blind, placebo-controlled crossover study in 50 active subjects (26M, 24F) examining single-dose Zynamite® PX (140 mg + quercetin) effects on repeated sprint performance. Published in Nutrients.
50 physically active subjects (26 men, 24 women). Acute crossover design.
Zynamite® PX improved peak power output by 2.8–3.8% during repeated Wingate sprints vs. placebo. Improved muscle oxygenation markers. Reduced perceived exertion at equivalent workloads. Both lipid-enhanced (with lecithin) and standard formulations effective.
Independent clinical study in national-level Greek basketball players examining pre-game Zynamite® PX supplementation effects on basketball-specific performance metrics.
38 male basketball players from Greece's top three national leagues. Randomized, double-blind, crossover study; single dose of Zynamite® PX (mango leaf extract with mangiferin + quercetin) vs placebo, 1 hour before intermittent high-intensity exercise. 24 circuits of 30-second activities measuring sprint and recovery metrics. Independent academic trial.
Mangiferin-quercetin supplementation significantly improved athletic performance metrics including sprint speed and reduced perceived exertion vs placebo. Confirms ergogenic effect previously seen in repeated sprint exercise (Gelabert-Rebato 2019, PMID 31731652, n=40 men+women) and exercise-mimetic skeletal muscle effects (2023 Nutrients).